CRISPR Therapy of Sickle Cell Disease: The Dawning of the Gene Editing Era.
The American journal of medicine, 137(5): 390-392 PMID 38184185 DOI 10.1016/j.amjmed.2023.12.018
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.